---
title: Regulators Are Cracking Down on 7-OH, the Gas-Station Opioid Sold in Candy-Flavored Gummies
description: The FDA calls 7-OH a potent opioid and the DEA has moved to schedule it. What the candy-flavored gas-station product is, why states ban it, and how to spot it.
author: Dr Marina Nani (Editor-in-Chief)
updated: 2026-09-08T23:19:08.160Z
canonical: https://richhealthmagazine.com/article/7-oh-gas-station-opioid-crackdown
image: https://cdn.nanimediahouse.com/7-oh-gas-station-gummies-272276.webp
categories: Health
content_type: News
region: United States
publication: Rich Health Magazine
schema_type: Article
---

The DEA on July 1, 2026 announced its intent to place certain concentrated and synthetic forms of 7-hydroxymitragynine, known as 7-OH, into Schedule I of the Controlled Substances Act. The notice, [published in the Federal Register on July 6](https://www.federalregister.gov/documents/2026/07/06/2026-13580/schedules-of-controlled-substance-temporary-placement-of-7-hydroxymitragynine-above-a-specified), cites a high potential for abuse and no accepted medical use. The proposed rule would cover 7-OH products above a 0.05 percent concentration threshold. As of early September 2026 that main order is not yet finalized, so 7-OH is not banned nationally.

The action follows a warning from the Food and Drug Administration, which describes concentrated 7-OH as a potent opioid and calls it an emerging public health threat. The FDA sent warning letters to sellers on July 15, 2025, and formally recommended on July 29, 2025 that the DEA schedule the substance. No FDA-approved drug contains 7-OH, and the agency says these products have not been proven safe or effective for any use.

Peer-reviewed studies the FDA cites put concentrated 7-OH at up to about 13 times the strength of morphine at the brain's mu-opioid receptors, the same receptors targeted by prescription painkillers and heroin. That potency is why some critics now call 7-OH “gas station heroin,” a nod to both its opioid activity and where shoppers find it.

## Sold as candy, stocked next to the register

7-OH is sold as tablets, gummies, powders, drink mixes, shots and dissolvable strips, according to the FDA, often in fruit flavors with colorful, candy-like branding. It turns up in smoke shops, gas stations and convenience stores as well as online. For a parent, that is the core of the concern: a product with opioid activity can sit near the checkout counter in packaging that looks closer to candy than to medicine.

Products may be labeled vaguely as “kratom extract” or “plant alkaloids,” and marketed under names including 7-OH, 7-Hydroxy, 7-HMG, 7-OHMG or 7-OH-mitragynine, which makes them hard to spot on a shelf. The FDA warns that anything promoted as “enhanced” or “spiked” kratom may contain far more 7-OH than occurs naturally in the leaf.

Natural kratom leaf contains only trace amounts of 7-OH, roughly 0.003 to 0.04 percent by dry weight. Concentrated and synthetic versions are tens of times more potent at opioid receptors. The DEA set its 0.05 percent threshold to separate botanical kratom leaf, which falls naturally below it, from concentrated and enhanced products that climb well above it.

The FDA links 7-OH to a range of adverse effects: addiction and dependence, anxiety, depression, gastrointestinal distress, insomnia, seizures, and opioid-type withdrawal symptoms. An estimated 1.7 million Americans aged 12 and older had used kratom in some form as of 2021, a measure of how large the broader market has grown.

## States moved before Washington did

Several states have already banned 7-OH rather than wait for the federal rule. Full kratom bans that include 7-OH are in place in Alabama, Arkansas, Indiana, Vermont, Wisconsin, Louisiana and Connecticut. Felony laws in Kansas and Tennessee took effect July 1, 2026. Massachusetts, North Dakota and Florida issued emergency orders in August 2026. At least 10 states now have bans or restrictions on the books.

Local governments have begun issuing their own warnings as the products spread. On September 8, 2026, the City of North Charleston, South Carolina, urged residents to learn about concentrated 7-OH and cautioned against products or online services promising a quick fix for 7-OH dependence, noting that no FDA-approved medication contains the substance.

One piece of the federal action is already final. The DEA placed three related synthetic compounds, MGPI, MGM-15 and MGM-16, on Schedule I effective August 26, 2026, while the main 7-OH order remains pending.

## The kratom industry is not opposing the ban

The American Kratom Association, the botanical-kratom industry's advocacy group, [supports scheduling concentrated 7-OH](https://www.americankratom.org/news/consumer-alert-on-7oh-products). Its position is that natural leaf kratom is a different product and should stay legal when properly formulated, labeled and age-restricted, summed up in its message that regulators should ban 7-OH because it is not kratom. The association has also warned that the crackdown could set a precedent later used against natural leaf, and on August 27, 2026 it filed suit over the scheduling of the three related compounds, fearing the rule could sweep in the trace amounts present in botanical kratom.

Criminalizing 7-OH could harm users without clear epidemiological proof of its dangers, some clinicians and harm-reduction advocates argue, and could cut off people who cannot access standard opioid-use treatment such as methadone or buprenorphine. Dr. Kirsten Smith has said that making it a criminal offense is not the direction the country needs to go.

## If someone you love is already using it

Dependence on 7-OH produces withdrawal that resembles opioid withdrawal, including anxiety, insomnia, muscle aches, sweating and cravings. Medical treatment for that dependence exists. A case series published in the Journal of Addiction Medicine in June 2026 described buprenorphine-based care for 7-OH dependence. People should not self-start such medication and should get a clinical evaluation first. For urgent concerns about an exposure, the national Poison Help line is 1-800-222-1222.

## FAQ

**Q: What is 7-OH, and how is it different from kratom?**
7-OH, or 7-hydroxymitragynine, is one of the alkaloids in the kratom plant, present only in trace amounts in the natural leaf. The products drawing regulatory attention are concentrated or synthetically produced versions that pack the compound at far higher levels. So 7-OH is a component of kratom, but concentrated 7-OH behaves much more like a strong opioid than the plain leaf does, which is the whole reason regulators treat the two differently.

**Q: Is 7-OH illegal?**
It depends on where you live and which product is in question. Federally, the DEA has announced its intent to place concentrated and synthetic 7-OH on Schedule I, but that order was not finalized as of early September 2026, so it is not yet banned nationwide. What is already enforceable sits at the state level, where more than 10 states have banned or restricted it, some treating possession as a felony and a few acting through emergency orders over the summer. Whether a specific product is legal where you are can also turn on its 7-OH concentration.

**Q: What are the side effects of 7-OH?**
The FDA links 7-OH to physical dependence and opioid-type withdrawal, meaning regular users can build a habit that is hard to break and feel sick when they stop. Reported effects also include anxiety, depression, insomnia, gastrointestinal distress and seizures. Because concentrated 7-OH acts strongly at the same receptors as prescription opioids, the risks the FDA describes are closer to those of an opioid than of a mild herbal supplement.

**Q: How can I tell if a product contains 7-OH?**
Read the ingredient panel for the compound under any of its names: 7-OH, 7-Hydroxy, 7-HMG, 7-OHMG or 7-OH-mitragynine. Be wary of vague terms like “kratom extract” or “plant alkaloids,” and of anything sold as “enhanced” or “spiked” kratom, which can carry far more 7-OH than natural leaf. A rough rule of thumb: if a kratom product comes as a single-serving shot, a flavored gummy or a dissolvable strip with candy-style branding, rather than loose powder or capsules of plain leaf, treat it as likely to be a concentrated 7-OH product and check the label closely.

**Q: What should someone do if they think a family member is dependent on 7-OH?**
Start with a licensed clinician rather than an online “quick fix,” which regulators have specifically warned against. Because 7-OH withdrawal mirrors opioid withdrawal, stopping abruptly can be rough, and clinicians have documented treating it with buprenorphine-based care, though no one should start that medication on their own. If there is an urgent worry about how much someone has taken, call the national Poison Help line at 1-800-222-1222, which is free and staffed around the clock.